“Get Ready to LOL at Elevance Health’s Q4 Earnings: Managed Care Crushes It Again!”
I can’t believe it’s true! Despite a 29% drop in Elevance Health’s stock, I still think it’s a strong buy! Why am I so confident, you ask? Well, let’s break it down. First off, let’s talk about that DCF price target of $549.60. That’s a 43% upside, my friends. Sounds pretty tempting, doesn’t it? I…